Vilafranca Del Penedes

Researchers are collecting detailed information about patients with venous thromboembolism (VTE), which includes blood clots in veins such as deep-vein thrombosis and pulmonary embolism. The project aims to improve doctors' understanding of VTE, especially in patients often excluded from clinical trials, like pregnant women, elderly individuals, cancer patients, and those with other complex health issues. The goal is to reduce deaths, clot recurrence, bleeding problems, and artery-related events by sharing this knowledge widely. The study involves gathering extensive data on each patient's health status, treatments, and outcomes during the first three months of therapy. This registry is available online to help doctors quickly find information on patients with similar medical profiles and make informed decisions about managing high-risk individuals. There are no specific interventions being tested; instead, the focus is on collecting real-world patient data. Participants provide informed consent and are followed for at least three years to monitor for new clot events and complications. Researchers track recurrences of VTE, bleeding episodes, and deaths, aiming to create tools that predict which patients are most at risk for problems. This ongoing data collection supports improving care and guiding treatment decisions for diverse patient groups over time.

Researchers are evaluating two care models to manage blood sugar levels in adults with type 2 diabetes who have poor metabolic control. The study compares the effects on glycated hemoglobin (HbA1c) three months after treatment between patients receiving care at a day hospital under the joint supervision of a nurse and an endocrinologist, and those followed up by a dietitian-nutritionist alongside an endocrinologist in an outpatient setting. This research aims to understand which care approach might better support blood sugar management in this patient group. Participants will be assigned to one of two groups: one receiving clinical follow-up at a Day Care Hospital involving both nursing and endocrinology care, and the other receiving follow-up care by a dietitian-nutritionist together with an endocrinologist in an ambulatory care unit. Both care models provide specialized support for managing diabetes, with different focuses on clinical management and nutritional guidance. During the study, participants' glycated hemoglobin levels will be measured three months after finishing the intervention to assess metabolic control. The study will monitor participants for any changes in diabetes management and health status, ensuring safety and collecting data to compare the outcomes of the two care models. This follow-up and measurement aim to provide insights into the effectiveness of these approaches for improving blood sugar control.

Researchers are evaluating the safety of remote consultations, including video and telephone visits, compared to traditional face-to-face consultations for patients with various clinical conditions usually followed in a secondary hospital. This randomized controlled trial aims to determine if remote consultations result in a similar frequency of complications of the underlying disease over a 12-month period, including any adverse reactions to treatment. The study includes adults and children who can participate in remote follow-up without requiring physical examinations and who have the necessary technology and skills for video consultations. Participants will be randomly assigned to one of three groups: the control group with face-to-face appointments, or one of two remote consultation groups using telephone or video calls. In the control group, face-to-face visits are the standard, with limited phone call interactions allowed. For remote consultations, patients will receive reminders and will either wait for a scheduled phone call or join a virtual waiting room for video calls. Physicians will schedule at least three visits, including a baseline screening visit, intermediate visits based on patient needs, and a final visit around 12 months after enrollment or sooner if necessary. During the study, participants will be regularly evaluated through these scheduled visits, and physicians can adjust appointments as needed. The main outcome measured is the occurrence of disease complications within 12 months. Researchers will track safety through monitoring complications and adherence to the assigned consultation method. The study will analyze results from participants who complete the study as planned without unapproved changes in consultation modes.